| (Values in U.S. Thousands) | Sep, 2020 | Jun, 2020 | Mar, 2020 | Dec, 2019 | Sep, 2019 |
| Sales | 12,460 | 11,200 | 18,170 | 14,810 | 14,260 |
| Sales Growth | +11.25% | -38.36% | +22.69% | +3.86% | +15.00% |
| Net Income | -2,130 | -1,420 | 2,300 | -330 | 3,350 |
| Net Income Growth | -50.00% | -161.74% | +796.97% | -109.85% | -34.06% |
Nuvo Research Inc (NRIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nuvo Pharmaceuticals Inc. is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. The company's product consists of Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch. Nuvo Pharmaceuticals Inc., formerly known as Nuvo Research Inc., is headquatered in Mississauga, Ontario.